The S&P 500 and Nasdaq hit record closing highs as hopes of a US Iran ceasefire extension boosted sentiment. Investors also digested US inf...

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...

Weight loss: A new study is challenging the popular “10,000 steps a day” rule, suggesting you may not need that much to protect your progre...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

Novo Nordisk is relaunching a diabetes tablet as Ozempic in the United States. This move aims to boost sales by using the strong brand reco...

More than 150,000 households face impact as SNAP benefits eligibility restrictions 2026 roll out with stricter rules this week. Florida has...

Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....

The US FDA has approved Eli Lilly's new weight-loss pill, Foundayo. This marks a significant step in the ongoing competition with rival Nov...

Eli Lilly has reduced the cost of its popular obesity drug Zepbound for American patients. This move aims to make the treatment more access...

Fortis Healthcare will expand its obesity clinic network. This decision follows increased demand for weight management solutions. Popular w...

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive its reputation ...

Dr. Morepen launched a new weight management program, LightLife, to combat India's rising obesity rates. The program uses scientifically-ba...

India's population is rapidly growing toward being overweight and obese.

The program will be digitally driven by a new app that will support virtual consultations, personalized diet and health monitoring, and eng...

Mindfulness training can improve the effectiveness of intensive weight management programmes.

London, June 3 (IANS) Unable to maintain weight loss due to your genetic predisposition to obesity? Take heart, an injectable drug widely u...

US has approved a first of its kind prescription drug to treat moderate to severe binge eating disorder (BED) in adults.